136 related articles for article (PubMed ID: 27298212)
1. Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR).
Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Rahbarnia L
Protein Expr Purif; 2016 Nov; 127():8-15. PubMed ID: 27298212
[TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of a Cetuximab-based Humanized Single Chain Antibody Against EGFR-overexpressing Tumors.
Veisi K; Farajnia S; Zarghami N; Khorshid HR; Samadi N; Safdari Y; Ahmadzadeh V
Drug Res (Stuttg); 2015 Dec; 65(12):624-8. PubMed ID: 25333654
[TBL] [Abstract][Full Text] [Related]
3. Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 Cells
Solis-Estrada J; Arredondo-Espinoza E; Pioquinto-Ávila E; González-Cruz AO; Zarate X; Balderas-Rentería I
Anticancer Res; 2024 May; 44(5):1955-1962. PubMed ID: 38677771
[TBL] [Abstract][Full Text] [Related]
4. Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab.
Ahmadzadeh V; Farajnia S; Hosseinpour Feizi MA; Khavarinejad RA
Protein Expr Purif; 2014 Oct; 102():45-51. PubMed ID: 25088934
[TBL] [Abstract][Full Text] [Related]
5. Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells.
Banisadr A; Safdari Y; Kianmehr A; Pourafshar M
Hum Vaccin Immunother; 2018 Apr; 14(4):856-863. PubMed ID: 29185855
[TBL] [Abstract][Full Text] [Related]
6. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Barzegar A; Rahbarnia L
Anticancer Drugs; 2017 Mar; 28(3):263-270. PubMed ID: 27861173
[TBL] [Abstract][Full Text] [Related]
7. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
8. Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.
Kim YP; Park D; Kim JJ; Chi WJ; Lee SH; Lee SY; Kim S; Chung JM; Jeon J; Lee BD; Shin JH; Lee YI; Cho H; Lee JM; Kang HC
PLoS One; 2014; 9(12):e113442. PubMed ID: 25438047
[TBL] [Abstract][Full Text] [Related]
9. Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system.
Asano R; Nakayama M; Kawaguchi H; Kubota T; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2012 Jan; 279(2):223-33. PubMed ID: 22074399
[TBL] [Abstract][Full Text] [Related]
10. humMR1, a highly specific humanized single chain antibody for targeting EGFRvIII.
Safdari Y; Farajnia S; Asgharzadeh M; Omidfar K; Khalili M
Int Immunopharmacol; 2014 Feb; 18(2):304-10. PubMed ID: 24370392
[TBL] [Abstract][Full Text] [Related]
11. Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.
Falahatgar D; Farajnia S; Zarghami N; Tanomand A; Khosroshahi SA; Akbari B; Farajnia H
Iran J Biotechnol; 2018 Dec; 16(4):e1743. PubMed ID: 31457033
[TBL] [Abstract][Full Text] [Related]
12. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
[TBL] [Abstract][Full Text] [Related]
13. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR).
Ahdi Khosroshahi S; Farajnia S; Ghiamirad M; Tanomand A; Veisi K; Rahbarnia L; Akbari B
Protein Expr Purif; 2016 Apr; 120():59-64. PubMed ID: 26690373
[TBL] [Abstract][Full Text] [Related]
15. Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli.
Akbari V; Sadeghi HM; Jafarian-Dehkordi A; Abedi D; Chou CP
Protein Expr Purif; 2015 Dec; 116():66-74. PubMed ID: 26166178
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic Chaperones Enhance Soluble Expression of Anti-EGFR huscFv in
Nazari A; Farajnia S; Zahri S; Bagherlou N; Tanoumand A; Rahbarnia L
Iran J Biotechnol; 2020 Apr; 18(2):e2314. PubMed ID: 33542937
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
[TBL] [Abstract][Full Text] [Related]
18. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
[TBL] [Abstract][Full Text] [Related]
19. [Construction and screening of phage antibody libraries against epidermal growth factor receptor and soluble expression of single chain Fv].
Sheng WJ; Miao QF; Zhen YS
Yao Xue Xue Bao; 2009 Jun; 44(6):597-602. PubMed ID: 19806889
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
